Brought to you by 
Adams Street and Latterell lead Naurex’s $18mm Series A financing
11 Jun 2021
Executive Summary
Adams Street Partners and Latterell Venture Partners co-led neurology therapeutics developer Naurex Inc.’s $18mm Series A financing, which also included investments by Druid BioVentures, Genesys Capital, PathoCapital, H. Lundbeck AS, Takeda Ventures, and Shire PLC. A member of PathoCapital has become the company’s chairman, and executives from Adams and Latterell joined the board.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Drug Discovery Tools
- Large Molecule
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Adams Street and Latterell lead Naurex’s $18mm Series A financing
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice